Read + Share
Perryman R, Renziehausen A, Shaye H, Kostagianni AD, et al. Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic
strategy for glioblastoma. Proc Natl Acad Sci U S A 2022;119:e2116289119.
PMID: 35917342
|
 |
|
Perryman R, Renziehausen A, Shaye H, Kostagianni AD, et al. Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic
strategy for glioblastoma. Proc Natl Acad Sci U S A 2022;119:e2116289119.
PMID: 35917342
|
|
|
|